New York Genome Center-founded Gencove has added $3m from investors including Alexandria Venture Investments to bring its genomics testing kit to new markets.

Gencove, a US-based genome sequencing platform developer spun out of biomedical research facility New York Genome Center, secured $3m on Wednesday in a round featuring Alexandria Venture Investments.
The deal, led by venture firm Spero Ventures, also featured Third Kind Venture Capital, Version One Ventures and Burst Capital. Alexandria Real Estate Equities is the strategic VC division of life sciences real estate investment trust Alexandria Real Estate Equities.
Founded in 2016, Gencove develops cost-effective genome sequencing technologies priced as low…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?